An Active Inference Approach to Dissecting Reasons for Non-Adherence to Antidepressants
Abstract
BackgroundAntidepressant medication adherence is among the most important problems in health care worldwide. Interventions designed to increase adherence have largely failed, pointing towards a critical need to better understand the underlying decision-making processes that contribute to adherence. A computational decision-making model that integrates empirical data with a fundamental action selection principle could be pragmatically useful in 1) making individual level predictions about adherence, and 2) providing an explanatory framework that improves our understanding of non-adherence. MethodsHere we formulate a partially observable Markov decision process model based on the active inference framework that can simulate several processes that plausibly influence adherence decisions. ResultsUsing model simulations of the day-to-day decisions to take a prescribed selective serotonin reuptake inhibitor (SSRI), we show that several distinct parameters in the model can influence adherence decisions in predictable ways. These parameters include differences in policy depth (i.e., how far into the future one considers when deciding), decision uncertainty, beliefs about the predictability (stochasticity) of symptoms, beliefs about the magnitude and time course of symptom reductions and side effects, and the strength of medication-taking habits that one has acquired. ConclusionsClarifying these influential factors will be an important first step toward empirically determining which are contributing to non-adherence to antidepressants in individual patients. The model can also be seamlessly extended to simulate adherence to other medications (by incorporating the known symptom reduction and side effect trajectories of those medications), with the potential promise of identifying which medications may be best suited for different patients.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 21
- FWCI
- 2.31
- Field percentile
- top 12%
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Low predictive power of clinical features for relapse prediction after antidepressant discontinuation in a naturalistic setting
Isabel M. Berwian, Julia G. Wenzel, … Quentin J. M. Huys·Biological PsychiatryPeer-reviewed·May 1, 2020
- An investigation into serotonergic and environmental interventions against depression in a simulated delayed reward paradigm
Bernd Porr, Alex Trew, Alice Miller·Adaptive BehaviorPeer-reviewed·Jul 26, 2019
- Conditioned versus innate effort-based tasks reveal divergence in antidepressant effect on motivational state in male mice
Foteini Xeni, Caterina Marangoni, … Megan G. Jackson·NeuropsychopharmacologyPeer-reviewed·Jun 2, 2025
- Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter, Stress Hormone, and Male Sex Hormone Systems
Mariam Bonyadi Camacho, Warut D. Vijitbenjaronk, Thomas J. Anastasio·Frontiers in PharmacologyPeer-reviewed·Oct 25, 2019
- Doing what's not wanted: Conflict in incentives and misallocation of behavioural control lead to drug-seeking despite adverse outcomes
Pranav Mahajan, Veeky Baths, Boris S Gutkin·Addiction NeurosciencePeer-reviewed·Jun 25, 2023
- Serotonin reuptake inhibition rapidly enhances affect-reward coupling and improves mood over time
Regan Mills, Anais Durand, … Liam Mason·bioRxiv·Jul 8, 2026